Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
UK MHRA commences accelerated review for AstraZeneca’s COVID-19 vaccine candidate
In rolling reviews, regulators can see clinical data in real-time and have discussions with pharma companies on manufacturing…
Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals
Immediate focus is to conduct Phase 3 trial successfully
Himachal Pradesh invites industry to sign MoU to set up units in proposed bulk drug park at Una
The State has identified 1,400 acres of land in Una for the bulk drug park and is promising competitive prices for land, power,…
The politics of pandemics
The COVID-19 pandemic is an opportunity to re-build better. At a global and national level, at a public health policy level as…
Express Pharma November 2020
India's Foremost Pharma & Biotech Magazine ~ Drugs & Cosmetics Act, 1940: Recommendations For A Revamp
Sun Pharma declares five-year positive results for ILUMYA (tildrakizumab-asmn)
ILUMYA is approved for adults with moderate-to-severe plaque psoriasis and is being evaluated for other possible uses
Study finds novel COVID-19 antibody therapy may reduce hospitalisations
The antibody slows down the replication process, allowing the patient's own immune system time to kick into gear
CDSCO asks Karnataka Drug Controller to take action against absent registered pharmacists
Requests to the state authority to examine the complaint and take stringent action as applicable under the provisions of Drugs and…
J&J to test COVID-19 vaccine in youths aged 12-18
Depending on safety and other factors, the company plans to test in even younger children afterwards
Aarti Drugs to expand metformin capacity to 3000 TPM
The company will start the Phase I expansion project to 2000 TPM in FY20-21